Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Inexpensive Multipurpose Point-of-Care Analyzer Unveiled at 2015 AACC Annual Meeting

By LabMedica International staff writers
Posted on 10 Aug 2015
An inexpensive point-of-care (POC) instrument capable of performing multiple clinical laboratory blood tests was unveiled at the 2015 AACC Annual Meeting & Clinical Lab Expo (Atlanta, GA, USA). More...


Investigators from DiaSys Diagnostics India (Mumbai, India) unveiled their new QDx InstaLab POC blood chemistry device. This instrument combines inexpensive microfluidic cartridge technology with novel nanomaterial-based plastic electrochemical biosensors.

The QDx InstaLab can perform all of the clinical tests that are routinely ordered as part of a yearly physical exam to evaluate organ function and check for conditions such as diabetes, liver disease, and kidney disease. Furthermore, the instrument can determine cholesterol levels and screen for bleeding problems.

The instrument was designed to perform these tests using samples comprising a few drops of blood from a finger prick. Results are available in three to 10 minutes or less.

“In areas where cost and efficiency are of paramount importance, labs will be able to consolidate all instrumentation into a single QDx InstaLab,” said Dr. Vijaywanth Mathur, head of research and development at DiaSys Diagnostics India. “This breakthrough technology will revolutionize and enable quality healthcare for all in low to middle income and high income countries, and particularly in rural, semirural, second tier, and third tier cities where there is no access to healthcare diagnostics or the cost per test is so high.”

Related Links:

2015 AACC Annual Meeting & Clinical Lab Expo
DiaSys Diagnostics India



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.